Table: Oncolys Biopharma - Q1 parent results

Oncolys Biopharma

12/05/2023 07:00

May 12 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            35 mln              193 mln                    
                 (-81.9 pct)                                      
  Operating     loss 325 mln        loss 384 mln                  
  Recurring     loss 323 mln        loss 349 mln                  
  Net           loss 323 mln        loss 328 mln                  
  EPS          loss 18.69 yen      loss 18.98 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T